Introduction: Coronavirus disease 2019 (COVID-19) is a systemic disease characterized by
a disproportionate inflammatory response in the acute phase. This study sought to identify …

Background and aims Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is
the sole causative agent of coronavirus infectious disease-19 (COVID-19). Methods and …

Recent works have demonstrated a significant reduction in cholesterol levels and increased
oxidative stress in patients with coronavirus disease 2019 (COVID-19). The cause of this …

Background The efficacy and safety of high versus medium doses of glucocorticoids for the
treatment of patients with COVID‐19 has shown mixed outcomes in controlled trials and …

Objectives To assess the influence of corticosteroid pulses on 60-day mortality in hospitalized
patients with severe COVID-19. Methods We designed a multicenter retrospective cohort …

BACKGROUND Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is the
causative agent of the ongoing coronavirus disease 2019 (COVID-19) pandemic. Understanding …

The different sets of criteria for diagnosis or classification of anti-neutrophil cytoplasmic
antibody-associated vasculitis (AAV) lead to numerous overlapping and reclassified diagnoses in …

Systemic lupus erythematosus (SLE) is a systemic autoimmune inflammatory disease of
unknown cause, with heterogeneity in its clinical presentation, as well as variability in its clinical …

Background Acute exacerbation of interstitial lung disease (AE-ILD) is a severe complication
with a poor prognosis. No clinical trials have supported the use of rituximab in AE-ILD …

TaggedPA 61-year-old woman was referred to our pulmonology department with a 2-month
history of dry cough and progressive dyspnea. She had been an active smoker (80 …